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Research
Most previous studies (D’Ippoliti et al. 2003; 
Peters et al. 2001, 2005; Pope et al. 2006; 
Zanobetti and Schwartz 2005), but not all 
(Sullivan et al. 2005), that have investigated 
the triggering of myocardial infarction (MI) 
by particulate matter (PM) air pollution con­
centrations in the hours and days before MI 
onset have reported an association. Other 
studies have reported increased mortality due 
to MI or increased mortality or cardiovascular 
admissions among MI survivors associated 
with increases in PM over the previous few 
days (Braga et al. 2001; von Klot et al. 2005; 
Zanobetti and Schwartz 2007). Several studies 
have investigated whether certain subgroups 
are particularly susceptible and have reported 
increased cardiovascular effects among 
those with diabetes (Dubowsky et al. 2006; 
Goldberg et al. 2001; Liu et al. 2007; O’Neill 
et al. 2005; Zanobetti and Schwartz 2002) 
and among patients with chronic obstruc­
tive pulmonary disease (COPD) (Naess 
et al. 2007; Zanobetti and Schwartz 2005; 
Zanobetti et al. 2000). However, Zanobetti 
and Schwartz (2005) reported increased sus­
ceptibility among patients with COPD but 
not among persons with diabetes.
Numerous researchers have reported that 
the percentage of infarctions that are nontrans­
mural has been increasing (Goff et al. 2000; 
Hellermann et al. 2003; Kostis et al. 2007; 
Myerson et al. 2009; Roger et al. 2006, 2010; 
Rogers et al. 2008). More recently, Shao (2008) 
noted a similar secular trend in clinical presenta­
tion of MI to emergency departments (EDs) in 
New Jersey. In short, 72% of persons admitted 
to hospitals in New Jersey from 1990 through 
1992 for MI had had trans  mural infarctions, 
and only 28% had had nontransmural infarc­
tions. Since then, however, this pattern has 
reversed. From 2002 through 2004, most of 
the admissions for MI were for nontransmural 
infarctions (63%), with only 37% for trans­
mural infarctions (Shao 2008). These changes 
may be due in part to improvements in preven­
tive pharmacotherapies (statins, beta blockers, 
aspirin), interventional procedures [angioplasty, 
coronary artery bypass graft (CABG)], more 
sensitive diagnostic tests (troponins), and treat­
ment of the MI upon ED arrival (reperfusion 
therapy, increased use of antiplatelet agents). It 
has not been reported whether PM with aero­
dynamic diameter ≤ 2.5 µm (PM2.5) triggers 
all infarctions, whether PM–MI associations 
differ in magnitude, or whether these asso­
ciations are restricted to PM–transmural or 
PM–nontransmural infarctions alone. Such 
investigations may provide insight into the 
mechanisms by which PM may trigger cardio­
vascular events.
Using the same data as Shao (2008), 
we attempted to replicate, in New Jersey, 
previous MI–PM2.5 studies that were con­
ducted in other U.S. and European cities. We 
hypothesized that increases in mean PM2.5 
concentration on the same day and a few 
days before ED arrival for MI may be associ­
ated with increased risk of MI and that these 
effect estimates would be greater for persons 
with diabetes and those with COPD than for 
individuals without these conditions. Further, 
we explored whether there were differences 
in risks associated with increases in ambient 
PM2.5 concentration between transmural and 
nontransmural infarctions.
Materials and Methods
Study population and outcome   definition. 
Using the Myocardial Infarction Data 
Acquisition System (MIDAS), a statewide sur­
veillance system in New Jersey that combines 
hospital discharge data and death certificate 
registration data (Kostis et al. 1994, 2001), 
we extracted all records with a primary diag­
nosis of acute MI [International Classification 
of Diseases, version 9 (ICD­9), codes 410.01, 
410.11, 410.21, 410.31, 410.41, 410.51, 
410.61, 410.71, 410.81, and 410.91] for 
patients who were admitted between 1 January 
2004 and 31 December 2006, were ≥ 18 years 
of age, were residents of New Jersey at the 
time of their MI, and who were without a 
previous diagnosis of MI (ICD­9 code 412). 
Because the “1” in the fifth digit of the ICD­9 
code (e.g., 410.01) indicates a first MI for 
the subject, we also used this designation to 
exclude those persons who had had a previ­
ous MI. Those who were not admitted into 
the hospital (e.g., patient declined admission, 
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Ba c k g r o u n d: Previous studies have reported increased risk of myocardial infarction (MI) after 
increases in ambient particulate matter (PM) air pollution concentrations in the hours and days 
before MI onset. 
oBjectives: We hypothesized that acute increases in fine PM with aerodynamic diameter ≤ 2.5 µm 
(PM2.5) may be associated with increased risk of MI and that chronic obstructive pulmonary disease 
(COPD) and diabetes may increase susceptibility to PM2.5. We also explored whether both trans-
mural and nontransmural infarctions were acutely associated with ambient PM2.5 concentrations. 
Me t h o d s : We studied all hospital admissions from 2004 through 2006 for first acute MI of adult 
residents of New Jersey who lived within 10 km of a PM2.5 monitoring site (n = 5,864), as well as 
ambient measurements of PM2.5, nitrogen dioxide, sulfur dioxide, carbon monoxide, and ozone. 
re s u l t s: Using a time-stratified case-crossover design and conditional logistic regression showed 
that each interquartile-range increase in PM2.5 concentration (10.8 µg/m3) in the 24 hr before arriv-
ing at the emergency department for MI was not associated with an increased risk of MI overall but 
was associated with an increased risk of a transmural infarction. We found no association between 
the same increase in PM2.5 and risk of a nontransmural infarction. Further, subjects with COPD 
appeared to be particularly susceptible, but those with diabetes were not. 
co n c l u s i o n s: This PM–transmural infarction association is consistent with earlier studies of PM 
and MI. The lack of association with nontransmural infarction suggests that future studies that inves-
tigate the triggering of MI by ambient PM2.5 concentrations should be stratified by infarction type.
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patient died before admission) were not 
included in this data set. We classified patients 
with an MI coded as 410.7 (subendocardial 
infarction) as having a nontransmural infarc­
tion, and those with codes 410.0 (infarction of 
anterolateral wall), 410.1 (infarction of other 
anterior wall), 410.2 (infarction of infero  lateral 
wall), 410.3 (infarction of infero  posterior 
wall), 410.4 (infarction of other inferior wall), 
410.5 (infarction of other lateral wall), and 
410.6 (true posterior wall infarction) as having 
transmural infarctions.
From these extracted data, we also 
retained the following variables: date and hour 
of ED admission; ZIP code of residence; age; 
sex; race; variables indicating the presence or 
absence of other comorbid conditions (based 
on ICD­9 codes)—congestive heart failure 
(ICD­9 code 428.0), arrhythmia (ICD­9 
codes 426.0, 426.10, 426.12, 426.2, 426.3, 
426.4, 426.5, 426.6, 426.89, 426.9, and 
427), hypertension (ICD­9 codes 401–405), 
diabetes (ICD­9 code 250), COPD (ICD­9 
codes 490–496), and history of ischemic heart 
disease (ICD­9 codes 410–414); and variables 
indicating in­hospital and postinfarction pro­
cedures (based on ICD­9 code)—angioplasty, 
CABG, and catheterization.
This study and the original MIDAS study 
were approved by the University of Medicine 
and Dentistry of New Jersey–New Brunswick 
Institutional Review Board. MIDAS was also 
approved by the New Jersey Department 
of Health and Senior Services Institutional 
Review Board.
Air pollution. Using ambient pollut­
ant measurements from the New Jersey 
Department of Environmental Protection and 
from U.S. Environmental Protection Agency 
(EPA) Web sites (U.S. EPA 2008), we used 
hourly concentrations of PM2.5 (7 monitoring 
stations), nitrogen dioxide (NO2; 9 stations), 
sulfur dioxide (SO2; 14 stations), carbon mon­
oxide (CO; 13 stations), and ozone (O3; 15 
stations) for the study period 1 January 2004 
to 31 December 2006. For each patient, we 
calculated the distance between each PM2.5 
monitor (in operation at the time of the 
MI) and the patient’s residence and assigned 
PM2.5 measurements from the closest monitor 
to their residence. Those patients who lived 
> 10 km from a PM2.5 monitoring station were 
excluded from PM2.5 analyses. We calculated 
mean PM2.5 concentrations for each succes­
sive 24­hr period before ED arrival for the MI 
(e.g., mean of hours 0–23 before ED arrival; 
24–47 mean of hours before ED arrival, etc.). 
If > 6 hr (> 25%) of a 24­hr period of PM2.5 
concentrations were missing, we set the mean 
for this 24­hr period of PM2.5 concentration 
to missing. We used these mean concentra­
tions in all analyses. We repeated this monitor 
matching and mean concentration calculation 
process for each of the other pollutants.
Weather. Hourly temperature and 
dew point measurements were made at the 
Newark, Caldwell, Somerset, and Trenton, 
New Jersey, airports during the study period. 
We used the airport monitor closest to each 
patient’s residence to provide the weather 
observations for that patient during the study 
period. After calculating 24­hr mean tem­
perature and dew point, in the same man­
ner as for the pollutant concentrations, we 
calculated 24­hr mean apparent temperature 
(Steadman 1979; Zanobetti and Schwartz 
2005) as a measure of each patient’s perceived 
air temperature given the humidity and used 
these values in all analyses.
Study design. We used a time­stratified 
case­crossover design (Levy et al. 2001; 
Maclure 1991) that has previously been 
used in studies of ambient air pollution 
and MI (D’Ippoliti et al. 2003; Pope et al. 
2006; Sullivan J et al. 2005; Zanobetti and 
Table 1. Frequency and percentage of characteristics of study population (cases matched to PM2.5 moni-
tors at ≤ 10 km distance): MIDAS study 2004–2006.
Total MI  
(n = 5,864)
Nontransmural MI  
(n = 3,822)
Transmural MI   
(n = 1,563)
Characteristic n (%) n (%) %
Age (years)
18–44 376 (6) 214 (6) 137 (9)
45–54 842 (14) 454 (12) 326 (20)
55–64 1,245 (21) 736 (19) 404 (26)
65–74 1,187 (20) 796 (21) 297 (19)
75–84 1,431 (25) 1,027 (27) 277 (18)
≥ 85 783 (14) 595 (15) 122 (8)
Sex
Male 3,296 (56) 2,048 (54) 980 (63)
Female 2,568 (44) 1,774 (46) 583 (37)
Race
White 4,027 (69) 2,625 (69) 1,079 (69)
Black 901 (15) 623 (16) 180 (12)
Other 936 (16) 574 (15) 304 (19)
Year
2004 1,634 (28) 1,066 (28) 452 (29)
2005 1,523 (26) 994 (26) 396 (25)
2006 2,707 (46) 1,762 (46) 715 (46)
Comorbidity
Hypertension 3,658 (62) 2,506 (66) 864 (55)
Diabetes mellitus 1,761 (30) 1,207 (32) 423 (27)
Type I diabetes 136 (2) 103 (3) 22 (1)
Type II diabetes 1,625 (28) 1,104 (29) 401 (26)
COPD 839 (14) 608 (16) 164 (10)
Pneumonia 445 (8) 350 (9) 60 (4)
Heart disease 5,100 (87) 3,373 (88) 1,326 (85)
Ischemic heart disease 3,603 (61) 2,285 (60) 1,052 (67)
Congestive heart failure 1,878 (32) 1,427 (37) 299 (19)
Atrial fibrillation 971 (17) 723 (19) 174 (11)
Arrhythmia 1,793 (31) 1,177 (31) 466 (30)
Ventricular tachycardia 332 (6) 173 (5) 129 (8)
In-hospital procedure
Angioplasty 786 (13) 393 (10) 350 (22)
CABG 288 (5) 202 (5) 60 (4)
Catheterization 3,178 (54) 1,908 (50) 1,028 (66)
Table 2. Distribution of daily mean PM2.5 concentrations at each monitoring station used.
Monitoring station
No. (%) of subjects 
matched to this monitor
Start and end dates of monitor 
during study period
No. of  
nonmissing days
PM2.5 concentration (µg/m3)
Minimum 25th Median 75th Maximum
Camden Lab 1,473 (25) January 2004–December 2006 986 0.5 6.7 11.1 17.0 52.2
Elizabeth Lab 2,009 (34) January 2004–December 2006 1,052 0 7.1 12.2 18.8 61.0
Flemington 35 (1) January 2006–December 2006 259 0 3.9 7.6 12.8 38.4
Jersey City 661 (11) January 2006–December 2006 336 1.4 6.0 9.7 18.2 46.9
Millville 148 (3) January 2006–December 2006 348 0.6 6.6 10.3 16.1 48.4
New Brunswick 1,131 (19) January 2004–December 2006 1,040 0.4 5.9 9.1 14.3 47.0
Rahway 407 (7) January 2006–December 2006 246 5.1 9.0 12.3 18.3 48.8Triggering of transmural infarctions by PM2.5
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Schwartz 2005), as well as other cardiovascular 
outcomes (Rich et al. 2005, 2006a, 2006b; 
Wellenius et al. 2005). In this design, each 
patient contributed information as a case dur­
ing the period immediately before the MI and 
as a matched control during times when an 
MI did not occur. The case­crossover design 
is analogous to a matched case–control study, 
but instead of estimating the relative risk of 
MI comparing exposure between persons (i.e., 
cases vs. controls), we estimated the relative 
risk of MI comparing exposure during differ­
ent time periods within the follow­up time of 
each case of MI. Because case periods and their 
matched control periods are derived from the 
same person and a conditional analysis is con­
ducted, non­time–varying confounders such 
as age, comorbidities, and history of long­term 
smoking were controlled by the study design. 
However, variables that may be related to both 
air pollution and the incidence of MI that 
vary over short time periods, such as weather 
conditions, which vary day to day, were pos­
sible confounders and were included in our 
analytic models. Case periods were defined as 
the 24­hr period before ED admission for MI, 
whereas control periods (three or four per case 
depending on the number of days in the cal­
endar month) were matched to the case period 
by day of the week, time of the day, year, and 
month. For example, if a person arrived at 
the ED with an MI at exactly 0000 hours on 
20 March 2009, then the 24­hr case period 
was the prior 24 hr (0000 hours to 2359 hours 
on Thursday 19 March), and the control peri­
ods were 0000 hours to 2359 hours on the 
three previous Thursdays (5, 12, and 26 March 
2009). Pollutant concentrations corresponding 
to these case and control periods were con­
trasted in all analyses.
Main analysis. Using a conditional logistic 
regression model stratified on each MI (one case 
and three or four control periods), we regressed 
case–control status (i.e., case period = 1, control 
period = 0) against the mean PM2.5 concen­
tration in the 24 hr before ED arrival. Using 
Akaike’s information criterion to select the opti­
mal lag time and number of degrees of freedom 
for apparent temperature, we also included a 
natural spline (3 degrees of freedom) of the 
mean apparent temperature in the 48 hr before 
ED arrival in the model. We then reran this 
same model, replacing the 24­hr mean PM2.5 
concentration (for both case and control peri­
ods) with one of six lagged mean PM2.5 con­
centrations (i.e., mean of hours 24–47, 48–71, 
72–95, 96–119, 120–143, or 144–167 before 
ED arrival) to estimate the risk of MI associated 
with each lagged PM2.5 concentration. From 
each model, we present the odds ratio (OR) 
and its 95% confidence interval (CI) scaled to 
the interquartile range (IQR) of PM2.5 observed 
during the study period. A p­value < 0.05 was 
used to indicate statistical significance.
Next, we examined whether the risk of 
MI associated with an IQR increase in mean 
PM2.5 concentration in the 24 hr before ED 
arrival was different for patients with transmu­
ral versus nontransmural infarctions. We reran 
the same model described above for patients 
with transmural infarctions only, and then 
for patients with nontransmural infarctions 
only. To examine potential effect modification 
by other factors, including COPD, diabetes, 
age (< 65 years, ≥ 65 years), sex, race (white, 
black, other), and season (winter = December, 
January, February; summer = June, July, 
August), we used an interaction term (e.g., 
COPD × PM2.5) in the main model.
Sensitivity analyses. To assess the stability 
of our PM2.5 relative risk estimates after adjust­
ing for gaseous pollutant concentrations, we 
created two­pollutant models (PM2.5 + NO2, 
PM2.5 + CO, PM2.5 + SO2, PM2.5 + O3) using 
mean pollutant concentrations from the 24 hr 
before ED arrival. We also evaluated whether 
any association between ED arrival for MI and 
the mean PM2.5 concentration in the previous 
24 hr was independent of concentrations from 
previous 24­hr periods. We reran the same 
conditional logistic regression model described 
above, including all seven lagged PM2.5 con­
centrations (i.e., the mean PM2.5 concentra­
tions from the 24 hr before ED arrival for MI, 
and the mean concentrations from the previous 
six lagged 24­hr periods).
All data sets included in the analyses were 
constructed using SAS software (version 9.1.3; 
SAS Institute Inc., Cary, NC), and all analy­
ses were conducted using R (version 2.6.1; 
R Foundation for Statistical Computing, 
Vienna, Austria). The authors had full access 
to the data and take responsibility for its 
integrity.
Results
During the study period, a total of 37,791 
patients were admitted to nonfederal New 
Jersey hospitals for a first acute MI; of these, 
5,864 lived within 10 km of a PM2.5 monitor­
ing site and had PM2.5 data available for analy­
sis (i.e., PM2.5 data available for at least 18 of 
the 24 hr before ED arrival for the index MI). 
Study patients were predominantly older (59% 
> 65 years of age), white (69%), and male 
(56%). Sixty­two percent had hyper  tension, 
61% had a history of ischemic heart dis­
ease, and 30% had diabetes (Table 1). Those 
who were excluded from our analysis were 
similar to persons who were included in age 
(61% > 65 years of age), sex (57% male), and 
comorbidities (e.g., 59% with hyper  tension), 
but they were slightly more likely to be white 
(82%). Subjects included in the analy  sis who 
experienced a nontransmural infarction were 
generally older and were more likely to have 
had cardiorespiratory comorbidities than were 
those who experienced a transmural infarc­
tion. Compared with the subjects who had 
a nontransmural infarction, those who had 
a transmural infarction were more likely to 
have had an angioplasty and/or catheteriza­
tion postinfarction but less likely to have had 
CABG (Table 1). Of note, there were seven 
monitors that made PM2.5 measure  ments in 
2006 but only three in 2004 and 2005, which 
resulted in a larger number of patients living 
within 10 km of a PM2.5 monitoring site and 
thus available for analysis in 2006 (Table 2).
Of the seven monitors that were con­
tinuously measuring PM2.5 during the study 
period, patients were most often assigned to 
the Elizabeth Lab (32%), Camden Lab (26%), 
and New Brunswick (18%) monitors. The dis­
tribution of mean daily PM2.5 concentrations 
at each of these seven monitors is shown in 
Table 2. When combining all the monitors, 
PM2.5 concentrations had a median of 11.7 
µg/m3; 5th and 95th percentiles of 3.6 and 
31.5 µg/m3, respectively; and 25th and 75th 
percentiles of 7.4 and 18.3 µg/m3, respectively 
(IQR = 10.8 µg/m3). We scaled all our effect 
estimates presented below by this IQR. Table 3 
shows Pearson correlation coefficients for indi­
vidual pollutants and apparent temperature.
Next, we separately estimated the risk of 
ED admission for MI associated with each 
IQR increase in the mean PM2.5 concentra­
tion in the previous 24 hr, and lagged 24­hr 
periods (hours 24–47, 48–71, 72–95, 96–119, 
120–143, and 144–167), adjusting for appar­
ent temperature during that same lag period. 
Each 10.8­µg/m3 increase in the mean PM2.5 
concentration in the 24 hr before ED arrival 
was not associated with an increased risk of MI 
(Table 4). Similarly, we found no associations 
between ED admission for overall MI and any 
of the lagged PM2.5 concentrations. However, 
when we then restricted our analysis to trans­
mural infarctions only we found a significantly 
increased risk associated with each 10.8­µg/m3 
increase in PM2.5 concentration in the previous 
Table 3. Pearson correlation coefficients for case and control period pollutant concentrations 
and apparent temperature.
Pollutant PM2.5 NO2 SO2 CO O3
PM2.5
NO2 0.44
SO2 0.44 0.56
CO 0.33 0.63 0.42
O3 0.19 –0.41 –0.32 –0.39
Apparent temperature 0.35 –0.23 –0.29 –0.11 0.56Rich et al.
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24 hr (OR = 1.10; 95% CI, 1.01–1.20). When 
examining lagged PM2.5 concentrations, the 
relative risk estimates were mostly > 1.0, but 
none was statistically significant. In contrast, 
when we restricted our analysis to nontrans­
mural infarctions, we found no increased risks 
associated with any lagged PM2.5 concentra­
tions (Table 4).
Because we found an association with 
transmural infarctions only, we restricted all 
further analyses to this infarction type and 
evaluated whether several factors modified this 
association. Patients with preexisting COPD 
and those < 65 years of age had substantially 
larger risks of transmural infarction associ­
ated with each 10.8 µg/m3 increase in PM2.5 
concentration in the previous 24 hr than did 
patients without preexisting COPD and those 
≥ 65 years of age (Table 5). We found no dif­
ference in PM2.5 relative risk estimates by race, 
sex, season, or whether subjects had diabetes 
(Table 5).
We then included mean PM2.5 and NO2 
concentrations from the 24 hr before ED arrival 
simultaneously in a model (n = 1,262 patients 
with transmural infarctions with both PM2.5 
and NO2 mean concentrations). The PM2.5 
relative risk estimate in this two­pollutant   
model was not substantially different from the 
single­pollutant model on the same n = 1,262 
patients (Table 6). This was also true when 
adjusting for CO, SO2, and O3. IQR increases 
in CO, SO2, and O3 were not associated 
with significantly increased risks of transmu­
ral infarctions in any single­ or two­pollutant 
model (Table 6). Next, when including all 
seven lagged PM2.5 concentrations in the same 
model, the risk associated with the 24­hr mov­
ing­average PM2.5 concentration was larger 
and still statistically significant (OR = 1.15; 
95% CI, 1.04–1.28). All the PM2.5 concen­
tration relative risk estimates for the other lag 
periods were smaller than the 24­hr moving­
average relative risk estimate, and none was 
statistically significant (data not shown).
Discussion
Using a large multiyear (2004–2006) statewide 
data set of hospital admissions for first MI, we 
found no association between admission for 
MI overall and PM2.5 concentrations in the 
previous week. However, when we restricted 
the analysis to patients with transmural infarc­
tions, we found a significant 10% increase in 
the risk of a transmural infarction associated 
with the mean PM2.5 concentration in the 
24 hr before ED arrival. This association per­
sisted with adjustment for gaseous pollutant 
concentrations in the prior 24 hr and with 
adjustment for PM2.5 concentrations during 
each of the previous six 24­hr periods. Further, 
patients with COPD, but not diabetes, were 
particularly susceptible to acute increases in 
ambient PM2.5 concentrations. We found no 
association with this same PM2.5 concentra­
tion and nontransmural infarctions.
Our findings are consistent with previous 
studies (D’Ippoliti et al. 2003; Peters et al. 
2001; Peters et al. 2005; Pope et al. 2006; 
Zanobetti and Schwartz 2005) in indicating an 
acute association between PM and MI onset, 
although the method of estimating MI onset 
time (day of hospital admission for MI, time 
of symptom onset estimated by patient, etc.), 
lags of pollutant concentrations examined (lag 
days 0–6, 0–6 lagged 24­hr periods before ED 
arrival for MI), and specific particle sizes exam­
ined (PM10, PM2.5) are not uniform. Previous 
studies reported PM associations with all MIs, 
not just transmural infarctions (D’Ippoliti et al. 
2003; Peters et al. 2001; Peters et al. 2005; 
Pope et al. 2006; Zanobetti and Schwartz 
2005). However, these studies drew data from 
earlier time periods [e.g., Peters et al. (2001), 
Boston, Massachusetts, 1995–1996; Peters 
et al. (2005), Augsburg, Germany, 1999–
2001; D’Ippoliti et al. (2003), Rome, Italy, 
1995–1997; Zanobetti and Schwartz (2005), 
21 U.S. cities, 1985–1999)] when most infarc­
tions were likely transmural. Therefore, their 
reports of increased relative risk of MI are 
consistent with our finding of increased rela­
tive risk of transmural infarctions only. Thus, 
our study adds to the body of knowledge that 
relates increased risk of MI with increases in 
PM in the previous hours and days, but ours is 
the first to report that associa  tions are restricted 
to transmural infarctions.
Pathophysiologic pathways proposed as 
mechanisms underlying previously reported 
PM/MI associations include systemic inflam­
mation, endothelial dysfunction, disturbance 
of autonomic tone, and enhanced coagulation/
thrombosis (Brook et al. 2004). Our finding 
of an acute (within 24 hr) association between 
PM and transmural infarctions, but not 
nontransmural infarctions, suggests another 
mechanism or pathway, perhaps related to 
those listed above, by which particles may 
trigger an MI. In a recent study, Bartoli et al. 
(2009) reported decreased myocardial blood 
flow in canines associated with concentrated 
air particles exposure, but not with filtered 
air exposure, after experimental occlusion of 
the coronary artery. Cardiac work was not 
Table 4. Estimated risk of ED admission for MI 
(95% CI) associated with each 10.8-µg/m3 
increase in moving average PM2.5 concentration, 
by infarction type.
Lag period
No. of 
  infarctions OR (95% CI)
All infarctions
0–23 5,864 1.02 (0.98–1.07)
24–47 5,838 1.01 (0.97–1.06)
48–71 5,821 0.99 (0.95–1.04)
72–95 5,784 1.01 (0.97–1.05)
96–119 5,795 1.02 (0.98–1.07)
120–143 5,786 1.00 (0.96–1.05)
144–167 5,770 1.00 (0.96–1.04)
Transmural infarctions
0–23 1,563 1.10 (1.01–1.20)
24–47 1,560 1.02 (0.93–1.11)
48–71 1,548 1.04 (0.96–1.13)
72–95 1,544 1.03 (0.95–1.12)
96–119 1,554 1.05 (0.97–1.13)
120–143 1,558 1.04 (0.97–1.13)
144–167 1,551 0.97 (0.90–1.05)
Nontransmural infarctions
0–23 3,822 0.99 (0.94–1.05)
24–47 3,803 1.00 (0.94–1.06)
48–71 3,805 0.96 (0.91–1.01)
72–95 3,771 0.98 (0.93–1.04)
96–119 3,773 1.01 (0.96–1.06)
120–143 3,766 0.99 (0.94–1.04)
144–167 3,758 1.00 (0.95–1.05)
Each estimate of the risk of MI associated with each IQR 
increase in lagged PM2.5 concentration was modeled 
separately, adjusting for apparent temperature during 
that same lag period.
Table 5. Risk of ED admission for transmural infarction (and 95% CI) associated with each 10.8-µg/m3 
increase in the mean PM2.5 concentration in the previous 24 hr.
Characteristic No. of infarctions OR (95% CI) p-Value for interaction
COPD
Yes 164 1.32 (1.05–1.66) 0.10
No 1,399 1.07 (0.98–1.18)
Diabetes
Yes 423 1.06 (0.90–1.23 0.54
No 1,140 1.11 (1.01–1.23)
Age (years)
< 65 867 1.18 (1.05–1.31) 0.05
≥ 65 696 1.01 (0.89–1.14)
Sex
Male 980 1.12 (1.01–1.24) 0.54
Female 583 1.07 (0.94–1.21)
Race
White 1,079 1.11 (1.01–1.23) —
Black 180 1.14 (0.93–1.41) 0.79a
Other 304 1.02 (0.84–1.23) 0.40b
Season
Winter 345 1.08 (0.90–1.30) 0.90
Summer 404 1.09 (0.94–1.26)
Each estimate of the risk of MI associated with each IQR increase in lagged PM2.5 concentration was modeled sepa-
rately, adjusting for apparent temperature during that same lag period.
aComparing black with white. bComparing other with white.Triggering of transmural infarctions by PM2.5
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increased by PM in this dog model, and data 
suggested that blood flow reductions were 
due to increased coronary vascular resistance, 
perhaps related to more limited recruitment 
of collateral vessels. Thus, particle inhalation, 
by reducing compensatory mechanisms, may 
transform limited (nontransmural) injury into 
more extensive (transmural) infarction. This 
finding is consistent with other research in 
which PM has been associated with increased 
rates of ST­segment depression in humans 
(Gold et al. 2005; Pekkanen et al. 2002) or in 
canine model markers of ischemia (Wellenius 
et al. 2003). There is also increasing support 
in the literature for the prothrombotic effects 
of air pollutants that indicates the possibil­
ity that limitations in revascularization after 
a primary plaque­related thrombotic event 
could be due to enhanced thrombosis in gen­
eral (Delfino et al. 2009; Jacobs et al. 2010; 
Lucking et al. 2008). A recent study that 
examined the association between PM and 
acute coronary events demonstrated greater 
relative risk in those individuals with angio­
graphically documented previous coronary 
disease (Pope et al. 2006). Future analyses 
using data from MIDAS will include exam­
ining differences in susceptibility to PM by 
prior disease events, including MI.
Ambient PM has previously been asso­
ciated with increased hospital admissions 
for COPD and asthma (Chen et al. 2004; 
Dominici et al. 2006; Medina­Ramon 
et al. 2006; Peel et al. 2005; Zanobetti and 
Schwartz 2003). COPD is associated with a 
greater propensity to hypoxia, reduced pul­
monary reserve, and a generally heightened 
inflammatory state, which all may predispose 
to transmural infarcts.
Although several researchers have reported 
acute associations between PM and cardio­
vascular outcomes in panels of patients with 
diabetes or have reported greater changes in 
cardiorespiratory biomarkers among those 
with diabetes than those without diabetes 
(Dubowsky et al. 2006; Goldberg et al. 2001; 
Liu et al. 2007; O’Neill et al. 2005; Zanobetti 
and Schwartz 2002), we did not find greater 
susceptibility to PM among patients with dia­
betes. Similar to the findings of Zanobetti and 
Schwartz (2005), we found larger relative risks 
for patients with COPD than for those with­
out this condition, but no difference in relative 
risk estimates for patients with diabetes versus 
those without diabetes.
Although our study has several strengths, 
including a large sample size, with subcatego­
ries of infarct and availability of continuous 
PM2.5 concentrations from seven monitor­
ing stations during the study period, several 
limitations should be considered when inter­
preting our results. First, this study relies on 
administrative data only, and therefore some 
of the outcomes coded as an MI may not have 
been an MI, or those classified as transmural 
may have been miscoded as nontransmural, or 
vice versa. Specifically, we were limited to only 
ICD­9 codes to classify an MI as a transmural 
or nontransmural. However, a data audit was 
previously conducted that verified the accu­
racy of MI diagnoses as well as the accuracy 
of information in the MIDAS data set (Kostis 
et al. 2001). Thus, any outcome misclassifi­
cation (MI vs. non­MI) was likely minimal. 
Further, any misclassification of transmural 
versus nontransmural was likely unrelated to 
ambient PM2.5 concentrations, resulting in 
nondifferential exposure misclassification and 
underestimates of relative risk.
Second, our data set included only those 
subjects who experienced an MI and were 
admitted to a hospital, and excluded MI 
patients who died before hospital admission. 
If PM does trigger transmural infarctions, 
which might have a higher out­of­hospital 
mortality rate, our data set would include a 
lower number of PM­triggered transmural 
infarctions than actually occurred during the 
study period. Therefore, our estimate of a 10% 
increase in the risk of a transmural infarction 
associated with each 10.8 µg/m3 increase in 
PM2.5 may be conservative.
Third, linking MIs to hourly and daily air 
pollution fluctuations requires minimizing mis­
classification of the estimate of MI onset time, 
so as to minimize bias. Although four previous 
studies (Peters et al. 2001; Peters et al. 2005; 
Pope et al. 2006; Sullivan J. et al. 2005) have 
used patients’ self­reported time of pain and 
symptom onset, this was not practical for our 
study, which relied on an administrative data 
set without personal interviews. Previous stud­
ies have reported median and mean delay times 
from symptom onset to ED arrival of 2.3–4.7 
hr (Goldberg et al. 2002), with 44% of MI 
patients in Massachusetts arriving within 2 hr, 
and 78% arriving within < 6 hr (Goldberg 
et al. 2000). Thus, because there is often a delay 
of several hours from symptom onset to ED 
arrival, use of ED arrival hour instead of hour of 
symptom onset results in greater exposure mis­
classification and bias toward the null. Further, 
in our analysis, the mean PM2.5 concentra­
tions in the 6, 12, and 24 hr before ED arrival 
were highly correlated (r­values = 0.83–0.95). 
Therefore, we did not examine associations 
with ambient PM2.5 concentrations < 24 hr 
before ED arrival, but instead focused on asso­
ciations between infarctions and the ambient 
air pollution concentration in the 24 hr before 
ED arrival for that MI. Our finding of an asso­
ciation between increased 24­hr mean PM2.5 
concentrations and transmural infarction needs 
to be replicated in a study that better estimates 
MI symptom onset time. This study would also 
allow a more proper investigation of the risk of 
a transmural infarction associated with PM2.5 
concentrations < 24 hr before MI symptom 
onset than is possible in our analysis.
Fourth, because all of the 24 hr used to 
calculate the mean PM2.5 concentration in 
the 24 hr before ED arrival may not have 
been before the onset of MI symptoms, this 
again was a source of nondifferential expo­
sure misclassification that may have resulted 
under  estimates of relative risk. As reported 
by Lokken et al. (2009), this error in estima­
tion of symptom onset time and the result­
ing relative risk–rate underestimation may be 
substantial in studies of acute cardiovascular 
and cerebro  vascular events and short­term 
increases in PM. When comparing relative 
risk estimates based on symptom onset of 
stroke versus those based on hospital presen­
tation for stroke, they observed an approxi­
mately 40% under  estimation of the relative 
risk of stroke when using time of hospital 
presentation (Lokken et al. 2009).
Last, we assigned PM2.5 concentrations to 
all patients who lived < 10 km from a PM2.5 
monitor, regardless of how close they lived to 
the monitor or how much time they spent at 
locations other than their residence. Because 
this error is not likely differential with respect 
Table 6. Risk of transmural infarction (and 95% CI) associated with each IQR increase in mean pollutant 
concentration in the previous 24 hr.
Pollutant Model type No. of   infarctions OR (95% CI)
PM2.5 Single pollutant 1,262 1.10 (1.00–1.21)
NO2 Single pollutant 1.11 (0.97–1.25)
PM2.5 Two pollutant 1.08 (0.96–1.22)
NO2 Two pollutant 1.04 (0.88–1.22)
PM2.5 Single pollutant 1,183 1.08 (0.98–1.19)
CO Single pollutant 1.02 (0.93–1.12)
PM2.5 Two pollutant 1.10 (0.98–1.22)
CO Two pollutant 0.97 (0.87–1.08)
PM2.5 Single pollutant 1,238 1.08 (0.98–1.18)
SO2 Single pollutant 1.02 (0.93–1.11)
PM2.5 Two pollutant 1.10 (0.98–1.24)
SO2 Two pollutant 0.96 (0.86–1.08)
PM2.5 Single pollutant 1,003 1.08 (0.97–1.21)
O3 Single pollutant 0.95 (0.81–1.12)
PM2.5 Two pollutant 1.08 (0.97–1.21)
O3 Two pollutant 0.95 (0.81–1.11)
IQR = 10.8 µg/m3 for PM2.5, 16 ppb for NO2, 0.35 ppm for CO, 4.1 ppb for SO2, and 18 ppb for O3.Rich et al.
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to when a patient had the MI, it likely resulted 
in nondifferential exposure misclassification 
and underestimates of relative risk. In the two 
pollutant analyses adjusting for gaseous pol­
lutant concentrations, gaseous pollutants may 
have greater degrees of spatial variability than 
does PM2.5 within this 10­km radius, resulting 
in residual confounding.
Conclusions
We found increased risk of transmural infarc­
tions, but not nontransmural infarctions, asso­
ciated with each 10.8 µg/m3 increase in mean 
PM2.5 concentration in the 24 hr before ED 
arrival. Further, patients with COPD, but not 
those with diabetes, appeared particularly sus­
ceptible to effects of ambient particles. If our 
findings are confirmed, future investigations of 
PM and MI triggering should stratify by type 
of MI, with particular emphasis on transmural 
infarctions. Future work should also investigate 
mechanistic explanations for these findings.
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